DNMT1 and neuroendocrine neoplasm: Short‐term epigenetic treatment with VPA and the DNMT inhibitor hydralazine had no stimulating effect on [68Ga]Ga‐DOTA-TATE uptake in nine patients with well‐differentiated neuroendocrine tumors with low baseline expression of SSTRs 69.